123 related articles for article (PubMed ID: 33138872)
1. How much change is enough? Evidence from a longitudinal study on depression in UK primary care.
Kounali D; Button KS; Lewis G; Gilbody S; Kessler D; Araya R; Duffy L; Lanham P; Peters TJ; Wiles N; Lewis G
Psychol Med; 2022 Jul; 52(10):1875-1882. PubMed ID: 33138872
[TBL] [Abstract][Full Text] [Related]
2. Minimal clinically important difference on the Beck Depression Inventory--II according to the patient's perspective.
Button KS; Kounali D; Thomas L; Wiles NJ; Peters TJ; Welton NJ; Ades AE; Lewis G
Psychol Med; 2015 Nov; 45(15):3269-79. PubMed ID: 26165748
[TBL] [Abstract][Full Text] [Related]
3. Comparison between self-administered depression questionnaires and patients' own views of changes in their mood: a prospective cohort study in primary care.
Hobbs C; Lewis G; Dowrick C; Kounali D; Peters TJ; Lewis G
Psychol Med; 2021 Apr; 51(5):853-860. PubMed ID: 31957623
[TBL] [Abstract][Full Text] [Related]
4. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
[TBL] [Abstract][Full Text] [Related]
5. Comparing the Beck Depression Inventory-II (BDI-II) and Patient Health Questionnaire (PHQ-9) depression measures in an integrated mood disorders practice.
Kung S; Alarcon RD; Williams MD; Poppe KA; Jo Moore M; Frye MA
J Affect Disord; 2013 Mar; 145(3):341-3. PubMed ID: 23021192
[TBL] [Abstract][Full Text] [Related]
6. Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials.
Bauer-Staeb C; Kounali DZ; Welton NJ; Griffith E; Wiles NJ; Lewis G; Faraway JJ; Button KS
J Clin Epidemiol; 2021 Sep; 137():200-208. PubMed ID: 33892086
[TBL] [Abstract][Full Text] [Related]
7. Comparing the Beck Depression Inventory-II (BDI-II) and Patient Health Questionnaire (PHQ-9) Depression Measures in an Outpatient Bariatric Clinic.
Schutt PE; Kung S; Clark MM; Koball AM; Grothe KB
Obes Surg; 2016 Jun; 26(6):1274-8. PubMed ID: 26341087
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity to change and minimal clinically important difference of Edinburgh postnatal depression scale.
Mao F; Sun Y; Wang J; Huang Y; Lu Y; Cao F
Asian J Psychiatr; 2021 Dec; 66():102873. PubMed ID: 34624746
[TBL] [Abstract][Full Text] [Related]
9. Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial.
Rifkin-Zybutz R; MacNeill S; Davies SJ; Dickens C; Campbell J; Anderson IM; Chew-Graham CA; Peters TJ; Lewis G; Wiles N; Kessler D
J Psychopharmacol; 2020 Dec; 34(12):1342-1349. PubMed ID: 33143538
[TBL] [Abstract][Full Text] [Related]
10. Anxiety and somatic symptoms among elderly patients with depression.
Grover S; Sahoo S; Chakrabarti S; Avasthi A
Asian J Psychiatr; 2019 Mar; 41():66-72. PubMed ID: 30054249
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
[TBL] [Abstract][Full Text] [Related]
12. Psychometric comparison of the PHQ-9 and BDI-II for measuring response during treatment of depression.
Titov N; Dear BF; McMillan D; Anderson T; Zou J; Sunderland M
Cogn Behav Ther; 2011; 40(2):126-36. PubMed ID: 25155813
[TBL] [Abstract][Full Text] [Related]
13. The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial.
Brabyn S; Araya R; Barkham M; Bower P; Cooper C; Duarte A; Kessler D; Knowles S; Lovell K; Littlewood E; Mattock R; Palmer S; Pervin J; Richards D; Tallon D; White D; Walker S; Worthy G; Gilbody S
Health Technol Assess; 2016 Nov; 20(89):1-64. PubMed ID: 27922448
[TBL] [Abstract][Full Text] [Related]
14. Relationship between change in social evaluation learning and mood in early antidepressant treatment: A prospective cohort study in primary care.
Hobbs C; Beck M; Denham F; Pettitt L; Faraway J; Munafò MR; Sui J; Kessler D; Button KS
J Psychopharmacol; 2023 Mar; 37(3):303-312. PubMed ID: 36000259
[TBL] [Abstract][Full Text] [Related]
15. What is the best screening test for depression in chronic spinal pain patients?
Choi Y; Mayer TG; Williams MJ; Gatchel RJ
Spine J; 2014 Jul; 14(7):1175-82. PubMed ID: 24225008
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
Wiles N; Thomas L; Abel A; Barnes M; Carroll F; Ridgway N; Sherlock S; Turner N; Button K; Odondi L; Metcalfe C; Owen-Smith A; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
Health Technol Assess; 2014 May; 18(31):1-167, vii-viii. PubMed ID: 24824481
[TBL] [Abstract][Full Text] [Related]
17. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
[TBL] [Abstract][Full Text] [Related]
18. Coexisting depressive symptoms do not limit the benefits of chronic neuromodulation: A study of over 200 patients.
Killinger KA; Fergus J; Edwards L; Boura JA; Bartley J; Gupta P; Tomakowsky J; Gilleran J; Peters KM
Neurourol Urodyn; 2018 Feb; 37(2):815-822. PubMed ID: 28762544
[TBL] [Abstract][Full Text] [Related]
19. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Maya J; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Overend K; Pasterfield M; Richards D; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; Gilbody S
Health Technol Assess; 2017 Feb; 21(8):1-196. PubMed ID: 28248154
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
